BBC vs. QQQS ETF Comparison
Comparison of Virtus LifeSci Biotech Clinical Trials ETF (BBC) to Invesco NASDAQ Future Gen 200 ETF (QQQS)
BBC
Virtus LifeSci Biotech Clinical Trials ETF
BBC Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Grade (RS Rating)
Last Trade
$27.70
Average Daily Volume
1,754
Number of Holdings
*
101
* may have additional holdings in another (foreign) market
QQQS
Invesco NASDAQ Future Gen 200 ETF
QQQS Description
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. The index excludes securities of issuers included in the Nasdaq-100 Index® (an index that measures the performance of 100 of the largest Nasdaq-listed non-financial companies by market capitalization) and the Nasdaq Next Generation 100 Index® (an index that measures the performance of the 100 largest Nasdaq-listed companies outside of the NASDAQ-100 Index® based on market capitalization). The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.81
Average Daily Volume
3,902
Number of Holdings
*
10
* may have additional holdings in another (foreign) market
Performance
Period | BBC | QQQS |
---|---|---|
30 Days | 1.92% | 3.41% |
60 Days | 6.21% | 9.07% |
90 Days | 11.94% | 9.16% |
12 Months | 41.96% | 18.90% |
1 Overlapping Holdings
Symbol | Grade | Weight in BBC | Weight in QQQS | Overlap | |
---|---|---|---|---|---|
IGMS | C | 1.77% | 0.83% | 0.83% |
BBC Overweight 100 Positions Relative to QQQS
Symbol | Grade | Weight | |
---|---|---|---|
SMMT | D | 2.14% | |
VRDN | B | 1.47% | |
LBPH | D | 1.33% | |
CNTA | B | 1.32% | |
APLT | C | 1.3% | |
PCVX | C | 1.26% | |
ACLX | C | 1.23% | |
EWTX | B | 1.21% | |
SAVA | D | 1.19% | |
ORIC | F | 1.15% | |
KYMR | D | 1.15% | |
NRIX | D | 1.14% | |
DNLI | C | 1.1% | |
ANAB | D | 1.09% | |
PTGX | C | 1.07% | |
IRON | C | 1.06% | |
WVE | C | 1.06% | |
NUVL | B | 1.04% | |
ERAS | D | 1.02% | |
COGT | B | 1.01% | |
ABUS | D | 1.0% | |
REPL | C | 0.98% | |
VKTX | C | 0.98% | |
TYRA | C | 0.97% | |
VERA | C | 0.96% | |
ALLO | D | 0.95% | |
AKRO | D | 0.95% | |
KROS | C | 0.94% | |
RVMD | B | 0.92% | |
ELVN | A | 0.91% | |
CGON | C | 0.9% | |
JANX | C | 0.9% | |
TERN | C | 0.89% | |
CRNX | C | 0.89% | |
RNA | B | 0.88% | |
IMVT | D | 0.87% | |
SVRA | F | 0.86% | |
ANNX | C | 0.85% | |
PHVS | F | 0.85% | |
XENE | D | 0.84% | |
ALEC | F | 0.83% | |
ARQT | D | 0.83% | |
DYN | D | 0.83% | |
CYTK | D | 0.82% | |
BEAM | F | 0.82% | |
OLMA | F | 0.81% | |
CMPS | F | 0.81% | |
QURE | F | 0.8% | |
XNCR | D | 0.79% | |
RLAY | F | 0.79% | |
BCYC | D | 0.79% | |
MLYS | C | 0.78% | |
CELC | F | 0.78% | |
PRTA | F | 0.78% | |
PLRX | F | 0.78% | |
SLN | D | 0.77% | |
SRRK | F | 0.77% | |
BLTE | B | 0.77% | |
ARVN | F | 0.77% | |
SNDX | F | 0.76% | |
KURA | F | 0.75% | |
IMTX | F | 0.75% | |
RCUS | D | 0.75% | |
CLDX | F | 0.75% | |
VERV | F | 0.74% | |
IMNM | F | 0.74% | |
RGNX | F | 0.68% | |
MRUS | D | 0.68% | |
RCKT | F | 0.67% | |
NTLA | F | 0.67% | |
IDYA | F | 0.66% | |
NUVB | F | 0.66% | |
AUTL | D | 0.66% | |
ETNB | F | 0.65% | |
ABCL | F | 0.65% | |
CGEM | F | 0.65% | |
LQDA | F | 0.62% | |
CVAC | F | 0.62% | |
RXRX | F | 0.61% | |
ARWR | F | 0.61% | |
VIR | F | 0.6% | |
ARCT | D | 0.58% | |
STOK | D | 0.58% | |
LRMR | F | 0.56% | |
MGNX | F | 0.56% | |
ITOS | F | 0.53% | |
EDIT | F | 0.52% | |
SANA | F | 0.5% | |
LYEL | F | 0.48% | |
PGEN | F | 0.46% | |
TSHA | F | 0.41% | |
FULC | F | 0.4% | |
FDMT | F | 0.37% | |
PRME | F | 0.36% | |
ZNTL | F | 0.33% | |
CABA | F | 0.28% | |
ALXO | F | 0.19% | |
SCLX | F | 0.14% | |
HLVX | F | 0.1% | |
AVTE | D | 0.07% |
BBC: Top Represented Industries & Keywords
QQQS: Top Represented Industries & Keywords
Industries:
Communication Equipment
Biotechnology
Diagnostics & Research
Internet Content & Information
Semiconductors
Solar
Specialty Chemicals
Keywords:
Telecommunications
Broadband
Backhaul
Biotechnology
Broadband Network
Communications Products
Computing
Digital Media
Ethernet
Microwave
Wireless Access
Wireless Networking
Access Management
Acid
Advertising Services
Alcohol
Antenna Systems
Antibodies
Antiprogestogens
Artificial Intelligence